- Home
- AXIL vs INKT Comparison
AXIL vs INKT Comparison
Compare AXIL & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXIL | INKT |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 45.2M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AXIL | INKT |
|---|---|---|
| Price | $7.09 | $10.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 10.8K | ★ 171.9K |
| Earning Date | 04-10-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $26,257,522.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $53.85 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.04 | $6.66 |
| 52 Week High | $10.25 | $76.00 |
Technical Indicators
Market Signals| Indicator | AXIL | INKT |
|---|---|---|
| Relative Strength Index (RSI) | 60.39 | 52.46 |
| Support Level | $4.76 | $8.48 |
| Resistance Level | $7.35 | $12.97 |
| Average True Range (ATR) | 0.36 | 0.96 |
| MACD | 0.14 | 0.18 |
| Stochastic Oscillator | 88.10 | 62.17 |
Price Performance
Historical ComparisonAbout AXIL AXIL Brands Inc.
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.